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Abstract. Magnetic Resonance Spectroscopy (MRS) provides valuable information to help
with the identification and understanding of brain tumors, yet MRS is not a widely available
medical imaging modality. Aiming to counter this issue, this research draws on the advance-
ments in machine learning techniques in other fields for the generation of artificial data.
The generated methods were tested through the evaluation of their output against that of
a real-world labelled MRS brain tumor data-set. Furthermore the resultant output from the
generative techniques were each used to train separate traditional classifiers which were tested
on a subset of the real MRS brain tumor dataset. The results suggest that there exist meth-
ods capable of producing accurate, ground truth based MRS voxels. These findings indicate
that through generative techniques, large datasets can be made available for training deep,
learning models for the use in brain tumor diagnosis.
1 Introduction
Within the UK over 11,000 brain tumor cases are diagnosed each year [5]. The survival rate and
period of progression have been shown to improve with treatment [22]. The process to determine
treatment can be difficult and time consuming [21], this is further complicated due to limited
numbers of staff available to perform these tasks [9]. These tasks also lead to the most errors in
diagnosis [9]. The automation of the tasks involved in diagnosis could help to increase the accuracy
and reduce the time it takes for the application of treatment to a patient.
Magnetic Resonance Spectroscopy (MRS), also known as MR Spectroscopic Imaging (MRSI) or
Chemical Shift Imaging (CSI), provides a non-invasive method for the diagnosis of human tissue
such as lung, bone or brain matter. Similar to MR Imaging (MRI), MRS is based upon the principles
of Nuclear Magnetic Resonance (NMR) [2]; however, whereas MRI uses the resultant proton signals
to create detailed graphical output, MRS uses the signals to determine the quantity in parts per
million (ppm) of various metabolites within cells [10] which can be seen in the example shown in
Figure 1. One area in which MRS has been shown to provide valuable insights is in the case of
brain tumors [11]. In medical imaging research, MRS has proven to produce accurate results in
identification of tumor grade classification [20, 11].
Current state-of-the-art computer vision models in medical imaging have begun to utilize the
advancements made in machine learning, specifically in the field of deep learning [14]. These deep
learning models take advantage of multi-layered networks to extract feature information from the
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Fig. 1: Example of a T1-Post MRI (a), Fluid-Attenuated Inversion Recovery (FLAIR) MRI (b),
Multi-Voxel MRS Heatmap overlaid on FLAIR (c) and the selected Single-Voxel MRS highlighted
in each of the images as the red square (d).
input data. To power the ability for these deep models to extract such feature-rich information,
large swaths of data are required [13]. This can be an obstacle in the medical imaging field as
restrictions in data protection [7] along with non-standardized practices makes it difficult to collect
the required amount of data to work with deep learning models. To be able to apply current state-of-
the-art classifiers to MRS brain tumor images more data is required, hence techniques to fabricate
or generate data are essential.
Advancements in computer vision and machine learning have also given the rise to accurate
generative techniques for the creation of artificial data. One such generative technique is Gener-
ative Adversarial Networks (GANs) [8] which have been developed to help create more domain
specific/accurate artificial data. GANs use multiple models working against each other to create
accurate data, with one model (Generator) attempting to produce artificial data capable of fooling a
model trained to determine real from fake data (Discriminator). By using approaches such as GANs
the process of creating data that adheres to the domain can be achieved. Recently, variations of
the original GAN model have been developed to produce better results. The Deeply Convolutional
GAN (DCGAN) [17], which takes into account the improvements that deep learning models have
shown against their traditional counterparts uses a multi-convolutional layered Generator and Dis-
criminator. Although GANs have been shown to produce accurate results in various fields [17, 19]
they are known to be unstable and hard to train [3] whereas their more linear counterparts are
considered to be easier to train but less expressive.
This paper applies three of the state-of-the-art methods in generating synthetic data (GAN,
DCGAN and a modified MRS brain tumor classifier [16]) to the domain of MRS for review. To
determine the accuracy of the artificial data created each generated dataset was used to train a
Random Forest for the classification of brain tumors. The results from the trained Random Forest
classifiers were bench-marked against the results of one trained on the real MRS images.
2 Materials & Methods
2.1 Materials
The MRS dataset used in this study was obtained by St. George’s University London and consisted
of a single-voxel MRS training and testing set. Both the test and training sets were acquired using
a GE Signa Horizon 1.5T MR system with a Repetition Time (TR) and a short Echo Time (TE)
of 2000ms and 30ms respectively. A Point-Resolved spectroscopic sequence protocol was used to
acquire the training and test dataset. The World Health Organization classifies tumours into 4
grades (WHO) [6]: Grades I - IV, with GI and GII being deemed low grade tumors and GIII and
GIV said to be high grade, malignant tumors. The composition of the training and test dataset
was 137 samples. Of the training set 70 were classified as healthy tissue, 20 as GII (low grade),
10 as GIII and 20 GIV (high grade). The test set consisted of 9 healthy, 3 low grade and 5 high
grade which were taken through random sampling of the entire dataset prior to training. Due to the
similarity between GIII and GIV tumour tissue in MRS imaging, the GIII data was merged with
the GIV data by labelling each as high grade. Figure 2 illustrates MRS spectra of different grades.
(a) Healthy Data. (b) Low Grade Data. (c) High Grade Data.
Fig. 2: Illustration of the MRS spectra grouped into 2a healthy (green), 2b low grade (blue) and 2c
high grade (red) tumor tissue. Peaks correspond to metabolites in the region of interest.
The positioning for every scan captured in the dataset was placed on a homogeneous, representa-
tive tumor region determined by an expert using post-Gd contrast T1w, T2w and FLAIR structural
contrast images alongside the relevant histopathological information. This was to ensure accuracy
within the training data and that there was a heterogeneity of MRS characteristics represented
within each voxel scanned. The individual labels for the data were achieved via the diagnosis of a
biopsy by a practiced physician in which the clinical, radiological and histopathological information
of each patient was incorporated to the diagnosis.
The nature of MRS data is high-dimensional (of roughly 1,024 dimensions) thus a reduction with
Principal Component Analysis (PCA) was applied to explore the data, see Figure 3. Clustering with
k-means results in a good separation of the classes, especially between healthy and high grade tissue
(Figure 3b).
2.2 Methods
This study took a three step approach. First, three different models (GAN, DCGAN and a generative
adaptation of PMM) were used to generated synthetic MRS images based off of the training -MRS-
dataset. Second, these samples were then each used to train a Random Forest to be able to classify
MRS images as either healthy, low or high grade tissue. Finally, the results from the Random Forest
(a) PCA applied with two components. (b) K-means clustering applied.
Fig. 3: Application of PCA to the MRS dataset with the first two components used 3a followed by
k-means clustering 3b.
classifiers were then analyzed and the synthetic data from the generative models were compared
against the mean signal of the training dataset classes.
The GAN model used in this study, based on [8], had a generator comprised of a fully connected
input layer which accepted a random value vector of size 100, with a hidden layer of 1,024 nodes in
size using rectified exponential linear (ReLU) [15] as the activation function with the output layer
having 1,024 nodes but utilizing TanH [1] as the activation function. The discriminator consisted
of a linear input layer which took in an MRS image of 1,024 values, followed by a hidden layer
consisting of 1,024 nodes using LeakyReLU [1] as the activation function, the output layer was a
singular sigmoidal node [18] activation. The full model was trained on each class of tissue for over
150,000 epochs using the Adam optimizer [12].
Compared to GANs, DCGANs use a deeper learning architecture which normally requires more
data. To try and generate more expressive and domain accurate data, alterations were required to
the training of the network to accommodate the limited data. The training process was modified to
not take random batch samples but to deliberately take the full set of the data available for training
at each epoch. The samples were then normalized with batch normalization. The architecture for the
generator used in the study was a fully connected input layer comprised of 2048 nodes followed by
four transposed one-dimensional convolutional layers using LeakyReLU as the activation function
for all but the output layer which used TanH. The discriminator was the inverse with the first four
layers being one-dimensional convolutions (using LeakyReLU as the activation function) followed
by a single Sigmodial output node. Similar to the GAN model the DCGAN model was trained for
at least 250,000 epochs on each tissue class.
GANs are a non-linear method for the generation of data which, theoretically, should lead to
more expressive data over that of more linear methods but to do so requires larger amounts of
training data. To test the benefits, a comparison to a linear based generator in the study was
required. For medical imaging data, factors such as patient orientation and relationship between
values matters. Therefore, testing requires a method which can generate data that adheres to the
domain. The selected method for this study was the Pairwise Mixture Model.
The Pairwise Mixture Model (PMM) [16] is a model for representing different brain tissue from
MRS images and based on the work by Asad et al. [4], the purpose of which was to solve the
problem of the heterogeneity of tissue types found within multi-voxel MRS images. The possible
types were defined as normal, low (GI and GII type brain tumour tissue) and high (GIII and GIV
brain tumour tissue). Each tissue model is expressed as a mean signal and the variation around
the mean, calculated from applying PCA to a labelled dataset of homogeneous MRS images each
relating to a specific grade. The models could then be as defined:
mi(t) = µi(t) +
∑
αieik(t), (1)
where µi is the mean signal, αi and ei respectively are the alpha weight coefficients and eigenvectors -
which encode the variation around the mean signal - with K representing the number of eigenvectors
determined for model mi. To calculate the amount of each tissue type found within a certain voxel
the assumption that each voxel was a weighted sum of the possible tissue types gives the following:
s(t) = wnmn(t) + wlml(t) + whmh(t), (2)
which can then be viewed as an optimization problem where:
E =
∫
[x(t)− s(t)]2dt+
∫
[
∑
j
s(t)− sj(t)]2dt, (3)
with j representing the available surrounding model signals of s(t).
The estimated coefficients can be considered to represent the amount of each tissue type (normal,
low or high) found within a voxel.
By taking the models of the various tissue types from the PMM, it is straightforward to see
how by varying the value of the coefficients of the models it is possible to create data that holds to
the original domain. There is a limit to the amount of possibly created data (c3 where c represents
the coefficients) but it is still enough to train a classifier model with a deep learning architecture,
based on the generated data alone.
The testing of the generated data from each network used a set of simple, shallow Random Forest
classifiers which were constructed and trained on the generated data from the GAN, DCGAN and
the PMM generation method. A Random Forest was also trained on the training dataset alone as
a control set. The Random Forest classifiers were then tested on the MRS image test set with the
classification accuracy results recorded and examined. Furthermore the generated MRS images were
compared to the mean signal from the training dataset for comparison to determine the adherence
to the domain and possibility of expressiveness.
3 Results
Each model, the GAN, DCGAN and PMM generator, was trained on the MRS single-voxel training
dataset for each class (normal, low and high). The GAN and DCGAN each had the architecture
detailed in Section 2.2.
From the results shown in Table 1 the GAN produced higher accuracy in the Random Forest
classifier trained on its data than with the DCGAN generated method for low grade tumor patients
and for normal (healthy) tissue. The classifier trained on PMM data produced higher accuracy for
Table 1: Table showing the resultant classification accuracy from the set of Random Forests trained
on the generated data from the GAN, PMM and the DCGAN compared to that of a Random Forest
trained on only the real, labelled training dataset (GT).
Grade PMM GAN DCGAN GT
Healthy 93% 97.5% 71% 96%
Low 96% 97% 66% 95%
High 93% 93% 71% 95%
Table 2: Table showing the mean squared error of the linear differences between the generated
signals and the mean signal of the ground truth data for each class
Grade PMM GAN DCGAN
Healthy 0.002 1.021 5.148
Low 0.004 2.044 4.063
High 0.071 3.029 12.001
low grade tumor patients over that of the ground truth. The DCGAN produced the worst results
over all tissue types.
The most variation within the resultant signals can be seen from both GAN methods, however,
the GAN appears to cohere closer to the shape of the real MRS signals as shown in Figure 4, this
can be shown through the deltas between signals shown in Table 2.
4 Conclusions
This paper examines the possibility of generating MRS brain tumor images from limited and uneven
data through one state-of-the-art generation technique, a deeper version of the same model and a
modified MRS brain tumor model (GAN, DCGAN and PMM respectively). The results showed
that the generated data could train a shallow Random Forest classifier to accurately determine the
grades of brain tissue to the same level of one trained on real MRS data. The GAN trained model
produced higher accuracy in testing and shows the expressiveness and capability in adversarial
networks whereas the DCGAN model produced the lowest accuracy in classification as well as in
similarity to the training data, highlighting the need for larger amounts of data when working with
deep learning models. The linear model was able to produce spectra that were closer in appearance
to the mean signal of the training dataset. The next stage is to examine the generated voxels by a
domain expert to acknowledge their potential accuracy and expressiveness, the analysis drawn can
then be used to determine what needs to be done in order to have the generated data successfully
train a deep learning model for the classification of MRS images.
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(a) GAN Healthy. (b) GAN Low Grade. (c) GAN High Grade.
(d) DCGAN Healthy. (e) DCGAN Low Grade. (f) DCGAN High Grade.
(g) PMM Healthy. (h) PMM Low Grade. (i) PMM High Grade.
(j) GT Healthy. (k) GT Low Grade. (l) GT High Grade.
Fig. 4: Artificially generated MRS signals of healthy (green), low grade (blue) and high grade (red)
tumor tissue produced from the PMM generation method 4g 4h 4i, the GAN 4a 4b 4c and the
DCGAN 4d 4e 4f compared with samples from the ground truth dataset 4j 4k 4l.
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